Wordt geladen...
Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection
BACKGROUND: The safety of immune checkpoint inhibitors (ICIs) in patients with hepatitis C virus (HCV) infection has not been studied in many cancers, as these patients were excluded from most ICI trials. This poses a degree of uncertainty when a patient with HCV is being considered for ICIs in the...
Bewaard in:
| Gepubliceerd in: | Oncologist |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Inc.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100564/ https://ncbi.nlm.nih.gov/pubmed/33655663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13739 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|